Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 25, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NOVATO, Calif., July 25, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on July 16, 2012, the compensation committee of BioMarin's board of directors approved...
July 11, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Host Second Quarter 2012 Financial Results Conference Call and Webcast on Wednesday, August 1 at 5:00 p.m. ET

NOVATO, Calif., July 11, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will host a...
June 19, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the NASDAQ OMX 28th Investor Program

NOVATO, Calif., June 19, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer at BioMarin, will present a...
June 07, 2012 16:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the William Blair Growth Stock Conference

NOVATO, Calif., June 7, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Steve Aselage, Chief Business Officer at BioMarin, will present a company update at the...
May 31, 2012 08:43 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Announces Pricing of Public Offering of Common Stock

NOVATO, Calif., May 31, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced the pricing of an underwritten public offering of 6,500,000 shares of its common stock. The...
May 30, 2012 16:43 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Announces Public Offering of Common Stock

NOVATO, Calif., May 30, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that it is offering to sell 6,500,000 shares of its common stock in an underwritten public...
May 30, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NOVATO, Calif., May 30, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that it has granted stock options, time-based restricted stock units and performance-based...
May 29, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the Jefferies Global Healthcare Conference

NOVATO, Calif., May 29, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Joshua Grass, Senior Vice President of Corporate and Business Development at BioMarin,...
May 29, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the Goldman Sachs Global Healthcare Conference

NOVATO, Calif., May 29, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will present a company...
May 08, 2012 16:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Appoints Dan Spiegelman as Executive Vice President and Chief Financial Officer

NOVATO, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today the appointment of Dan Spiegelman as Executive Vice President and Chief Financial Officer...